Kymera Therapeutics, Inc. (KYMR) › Operating IncomeKymera Therapeutics, Inc. (KYMR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$42.20M2020: -$46.30M2021: -$100.53M2022: -$161.26M2023: -$165.53M2024: -$261.63M2025: -$349.40M-$349.40M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$349.40M-33.5%2024-$261.63M-58.1%2023-$165.53M-2.7%2022-$161.26M-60.4%2021-$100.53M-117.1%2020-$46.30M-9.7%2019-$42.20M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share